Ivermectin, Pyrantel Pamoate, Praziquantel

Verify with FDA CVM →

854 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
854
Total Reports
27
Deaths Reported
320.0%
Death Rate

Active Ingredients

Ivermectin, Pyrantel Pamoate, Praziquantel

Administration Routes

OralUnknownIntrauterineTopical

Species Affected

Dog 807
Unknown 40
Human 5
Cat 1
Rabbit 1

Most Affected Breeds

Crossbred Canine/dog 103
Retriever - Labrador 91
Dog (unknown) 68
Unknown 45
Shepherd Dog - German 40
Terrier - Yorkshire 33
Retriever - Golden 32
Chihuahua 30
Shih Tzu 29
Poodle (unspecified) 23

Most Reported Reactions

Vomiting 255
INEFFECTIVE, HEARTWORM LARVAE 203
INEFFECTIVE, ASCARIDS NOS 84
Lack of efficacy (endoparasite) - hookworm 84
Depression 81
Diarrhoea 62
Lack of efficacy (endoparasite) - tapeworm 53
Underfilling, Package 32
Anorexia 30
Accidental exposure 29
Convulsion 20
Lack of efficacy (endoparasite) - heartworm 18

Outcome Breakdown

Outcome Unknown
32 (47.8%)
Died
27 (40.3%)
Recovered/Normal
5 (7.5%)
Ongoing
3 (4.5%)

Data Summary

Metric Value
Total adverse event reports 854
Reports involving death 27
Case-fatality rate (reported events) 320.0%
Distinct species in reports 5
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Ivermectin, Pyrantel Pamoate, Praziquantel Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 854 adverse event reports referencing Ivermectin, Pyrantel Pamoate, Praziquantel, including 27 reports in which the animal died — a 320.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Ivermectin, Pyrantel Pamoate, Praziquantel. Reported administration routes include Oral, Unknown, Intrauterine, Topical. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Ivermectin, Pyrantel Pamoate, Praziquantel reports are Dog (807 reports), Unknown (40 reports), Human (5 reports), with Dog accounting for the largest share. Within those species, Crossbred Canine/dog (103), Retriever - Labrador (91), Dog (unknown) (68) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Ivermectin, Pyrantel Pamoate, Praziquantel are Vomiting (255), INEFFECTIVE, HEARTWORM LARVAE (203), INEFFECTIVE, ASCARIDS NOS (84), Lack of efficacy (endoparasite) - hookworm (84). Of the 67 reports with a coded outcome, Outcome Unknown is the leading category at 47.8%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Ivermectin, Pyrantel Pamoate, Praziquantel.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial